Ayala Pharmaceuticals Inc

Ayala Pharmaceuticals Inc

AYLA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.25M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ayala Pharmaceuticals IncAyala Pharmaceuticals Inc-0.1-3459%--1.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$8.25 Million
Enterprise Value$7.59 Million
Earnings per Share$-2.46
Beta0
Outstanding Shares15,448,931

Return

Return on Equity3458.87%ROE
Return on Assets-829.80%
Return on Invested Capital1266.63%

Valuation & Multiples

P/E Ratio-0.08P/E Ratio
PEG-0.59PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.53Price to Book Ratio
Enterprise Value to Revenue-0.95
Enterprise Value to EBIT0.02
Enterprise Value to Net Income-1
Total Debt to Enterprise-2.67
Debt to Equity-1.59Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Ayala Pharmaceuticals Inc

Ayala Pharmaceuticals Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.